## IP: International Paper Company - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 0.3% below STRENGTH zone (3.0-6.0%); PEG 1.21 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. International Paper (IP): Evaluating Valuation After a Year of Weak Share Performance and Rebounding Earnings**
- Source: Simply Wall Street | 20251221T120807 | Somewhat-Bullish | Relevance: 100%
- Despite a significant share price decline over the past year, International Paper (IP) shows improving revenue and a sharp rebound in net income growth. The company is considered 20.5% undervalued with a narrative fair value near $48, predicated on strategic investments in automation and manufacturing improvements aimed at reducing costs and expanding margins. However, potential risks like chronic mill reliability issues and sluggish containerboard demand could impact these expectations.

**2. International Paper (IP): Evaluating Valuation After a Year of Weak Share Performance and Rebounding Earnings**
- Source: Simply Wall Street | 20251221T120758 | Somewhat-Bullish | Relevance: 100%
- International Paper (IP) has seen weak share performance over the past year despite improving revenue and a sharp rebound in net income. The company is currently considered undervalued with a narrative fair value near $48, driven by expected cost reductions and margin expansion from capital investments. However, potential risks like mill reliability issues and sluggish containerboard demand could delay this recovery.

**3. International Paper (IP) Maintains 'Buy' Rating, Price Target Cut to $50**
- Source: GuruFocus | 20251222T150837 | Neutral | Relevance: 100%
- Argus Research has maintained a 'Buy' rating on International Paper (IP) but lowered its price target from $55.00 to $50.00, reflecting a continued positive outlook despite the adjustment. This decision comes amidst other analyst revisions, with the average one-year price target from 10 analysts suggesting a 25.06% upside from the current price, while GuruFocus estimates a 12.03% downside based on its GF Value.

**4. Fanfold Market Is Going to Boom |• Domtar Corporation • International Paper**
- Source: openPR.com | 20251223T080810 | Somewhat-Bullish | Relevance: 100%
- Worldwide Market Reports has released a new research study predicting substantial growth for the "Fanfold Market." The report offers a comprehensive analysis including market dynamics, drivers, restraints, growth opportunities, and competitive analysis, supported by extensive primary and secondary research. It also provides regional insights, revenue forecasts, and profiles of key players like Domtar Corporation and International Paper.

**5. unimaginative title**
- Source: openPR.com | 20251223T080802 | Somewhat-Bullish | Relevance: 63%
- This report by Worldwide Market Reports analyzes the THEIC market, projecting substantial growth in the coming years. It provides a comprehensive overview including market dynamics, competitive analysis, regional insights, and growth opportunities. The study covers key players like BASF and Eastman Chemical Company, segmentation by types and applications, and aims to provide actionable intelligence for business growth.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Argus Research | $50 | $55 | -9% |
| 2025-12-05 | JP Morgan | $46 | $48 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Argus Research | main | Buy |
| 2025-12-05 | JP Morgan | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.69M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 67.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Price (T.Rowe) Assoc: 12.5% (+23.2%)
- Vanguard Group Inc: 12.1% (+0.3%)
- Capital Research Glo: 10.3% (+7.4%)
- Capital Internationa: 9.3% (+51.3%)
- Blackrock Inc.: 7.8% (-1.1%)

### Key Risks

1. Elevated short interest (13.3%): bears positioning against stock.
2. Long-term trend broken: trading 15.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.21 suggests fair value with growth premium. Forward P/E 17.9x attractive for 745% earnings growth. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.8B |
| Beta | 1.06 |
| 52W Range | $35.56 - $60.15 |
| Short Interest | 13.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.21 |
| Forward P/E | 17.9 |
| Current P/E | 151.6 |
| YoY Growth | 744.7% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 2.9% to 0.3% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >3.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.85x), long-term trend not supportive. RSI neutral at 53. OFD pattern: +DLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.31% (CS: 76) | Neutral |
| RSI_14 | 52.9 | Neutral |
| MACD Histogram | 0.22 | Bullish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 0.978x | Below |
| vs SMA200 | 0.850x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.45
- **Stop Loss:** $37.47 (5.0% risk)
- **Target:** $41.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 454
- **Position Value:** $17,910.30
- **Portfolio %:** 17.91%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.59 | $-0.43 | -173.0% |
| 2025Q2 | $0.41 | $0.20 | -51.1% |
| 2025Q1 | $0.37 | $0.23 | -38.0% |
| 2024Q4 | $0.03 | $-0.02 | -175.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*